EUCTR2010-023245-30-IT进行中（未招募）不适用
Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis - ND
ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI0 个研究点开始时间: 2010年12月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Chronic hepatitis C
- •- End stage renal disease(eGFR < 50ml/min/1.73 mq di s.c.) in dialysis;
- •- Possibility to enter a transplantation list;
- •- Absence of pregnancy or breastfeeding;
- •- signature of informed consent;
- •- availability to use appropiate contraceptive method.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Age< 18 years or >65 years;
- •- Patients oin treatment with immunomodulant or antineoplastic drugs;
- •- cirrhosis;
- •- Hematopoietic system disorders;
- •- Baseline Hb<8 gr/dl and/or Neutrophyls count<1000/mmc and/or platelet count<100000/mmc;
- •- History of epilepsy, psychiatric disorders, cardiovascular diseases in the last 6 months befor study entry, decompensated diabetes, respiratory disorders;
- •- Immunologic diseases that require steroid therapy;
- •- Ocular diseases;
- •- Acute infectious diseases;
- •- Transplanted patients;
- •- Allergy to study drugs.
研究者
相似试验
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studyEUCTR2004-004736-30-ATErasmus MC122
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studychronic HBeAg-negative hepatitis BEUCTR2004-004736-30-DEFoundation of Liver research122
进行中（未招募）
不适用
COMBINED THERAPY WITH PEG-INTERFERON-a, RIBAVIRIN AND RITUXIMAB OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA - NDpatients anti-HCV, HCV RNA positivity, Na?ve, with cryoglobulinemic vasculitis (detection of serum cryoglobulins associated with purpura, arthralgias and weakness)and with chronic hepatitisMedDRA version: 9.1Level: SOCClassification code 10005329EUCTR2010-020659-30-ITAZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
已完成
4 期
Peginterferon-alpha plus ribavirin therapy following twice-daily administration of interferon-beta in patients with genotype 1 and high viral load.patients with HCV genotype 1 and high viral loadJPRN-UMIN000003410Gunma Liver Study Group35
进行中（未招募）
不适用
Terapia PEG-Interferone alfa 2B+Ribavirina versus terapia PEG-Interferone alfa 2B + Ribavirina+ Terapia ormonale sostitutiva (TOS) nella prevenzione della progressione della fibrosi epatica nell’epatite cronica HCV positiva in eta' post-menopausale - NDWomen in post-menopause with Chronic HCV positive hepatitisMedDRA version: 9.1Level: SOCClassification code 10019805Term: Hepatobiliary disordersEUCTR2008-001260-36-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA